Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She has also held the prestigious Rosalind Franklin fellowship.
Specific immune system cells that accumulate in higher than usual numbers in the lung tissue of people with bronchiectasis, called antigen presenting cells (APC), may contribute to airway inflammation, researchers reported. The study, ... Read more
California-based Raptor Pharmaceutical, a global biopharma that specializes in the development and commercialization of treatments for rare and debilitating diseases, recently announced that the U.S. FDA designated its inhaled levofloxacin treatment, MP-376, as a ... Read more